SCM

Stonepine Capital Management Portfolio holdings

AUM $102M
This Quarter Return
-19.32%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$114M
AUM Growth
+$114M
Cap. Flow
-$27.8M
Cap. Flow %
-24.42%
Top 10 Hldgs %
77.21%
Holding
33
New
2
Increased
7
Reduced
13
Closed
11

Top Buys

1
NEOS
Neos Therapeutics, Inc
NEOS
$6.57M
2
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$5.44M
3
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$2.66M
4
OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$2.49M
5
AFMD
Affimed
AFMD
$2.22M

Top Sells

1
ATXS icon
Astria Therapeutics
ATXS
$9.27M
2
MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
$7.74M
3
AMRN
Amarin Corp
AMRN
$5.44M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
$4.11M
5
KALV icon
KalVista Pharmaceuticals
KALV
$3.05M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AMRN
1
Amarin Corp
AMRN
$311M
$15M 13.15% 1,100,000 -400,000 -27% -$5.44M
BDSI
2
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$14.7M 12.94% 3,981,867 -329,236 -8% -$1.22M
BSTC
3
DELISTED
BioSpecifics Technologies Corp.
BSTC
$13.2M 11.57% 217,395 -67,864 -24% -$4.11M
CPIX icon
4
Cumberland Pharmaceuticals
CPIX
$52.2M
$7.92M 6.96% 1,313,429 +95,028 +8% +$573K
APEN
5
DELISTED
Apollo Endosurgery, Inc.
APEN
$7.54M 6.62% 2,185,426 -392,570 -15% -$1.35M
NEOS
6
DELISTED
Neos Therapeutics, Inc
NEOS
$6.95M 6.1% 4,210,153 +3,982,234 +1,747% +$6.57M
HTGM
7
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$6.8M 5.97% 2,675,889 +2,140,299 +400% +$5.44M
VNDA icon
8
Vanda Pharmaceuticals
VNDA
$279M
$5.77M 5.07% 220,848 -103,752 -32% -$2.71M
OPNT
9
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$5.17M 4.54% 357,960 +172,073 +93% +$2.49M
ISEE
10
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4.89M 4.29% 4,072,301 +1,747,519 +75% +$2.1M
ALIM
11
DELISTED
Alimera Sciences, Inc.
ALIM
$4.7M 4.13% 6,547,774 -440,082 -6% -$316K
FOMX
12
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$4.64M 4.08% 1,293,177 +742,099 +135% +$2.66M
CTIC
13
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$4.2M 3.69% 5,726,579 +424,516 +8% +$311K
VIVE
14
DELISTED
VIVEVE MED INC
VIVE
$3.59M 3.15% 3,418,402 -431,309 -11% -$453K
OXFD
15
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.84M 2.5% 222,321 -3,556 -2% -$45.4K
AFMD
16
DELISTED
Affimed
AFMD
$2.22M 1.95% +714,079 New +$2.22M
CORV
17
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$1.06M 0.93% 424,101 -474,056 -53% -$1.18M
CEMI
18
DELISTED
Chembio diagnostics, Inc.
CEMI
$832K 0.73% +147,011 New +$832K
ATEC icon
19
Alphatec Holdings
ATEC
$2.35B
$775K 0.68% 338,278 -413,478 -55% -$947K
MTEM
20
DELISTED
Molecular Templates, Inc.
MTEM
$463K 0.41% 114,710 -263,585 -70% -$1.06M
NVLN
21
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$447K 0.39% 531,662 -1,197,225 -69% -$1.01M
ATXS icon
22
Astria Therapeutics
ATXS
$349M
$182K 0.16% 41,688 -2,124,466 -98% -$9.27M
ALDX icon
23
Aldeyra Therapeutics
ALDX
$351M
– – -145,000 Closed -$2M
CDTX icon
24
Cidara Therapeutics
CDTX
$1.66B
– – -656,148 Closed -$2.89M
KALV icon
25
KalVista Pharmaceuticals
KALV
$678M
– – -138,100 Closed -$3.05M
1
2